• Cancer Antigen (CA) 19-9, Pancreatic Cyst Fluid
  • Catechol-O-methyltransferase Genotyping (COMT)
  • Aldosterone, Urine
  • Prolactin
  • Splicing Factor 3b Subunit B1 (SF3B1) Gene Mutation Analysis
  • CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • Endometrial stromal sarcoma
  • Alpha 1 Antitrypsin, Serum
  • Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS
  • Malignant neoplasm, renal pelvis (kidney)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
Medical Test

Overview
Access to Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS) is restricted.
Loading...